| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $774,411 ) |
| | 2025 | 2025 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R21HD114232 | Functional longevity of maternally derived antibodies against group B Streptococcus and respiratory syncytial virus in HIV-exposed uninfected and HIV-unexposed uninfected infants. | 000 | 2 | NIH | 12/19/2024 | $114,410 |
| | 2025 | 2025 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 19 | NIH | 11/19/2024 | $1,155,784 |
| | 2025 | 2025 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 19 | NIH | 11/19/2024 | $438,228 |
| | 2025 | 2025 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH125053 | 3/3 Genomics of Schizophrenia in the South African Xhosa | 000 | 5 | NIH | 12/12/2024 | $524,661 |
| | 2025 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 000 | 4 | NIH | 1/24/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HL135600 | Sickle Africa Data Coordinating Center | 000 | 8 | NIH | 1/16/2025 | $76,212 |
| | 2025 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011442 | Psychosocial distress, inflammatory reactivity and central sensitization in the pathway to HIV-related pain: characterizing the associations and developing a pragmatic, coping-focused intervention. | 000 | 5 | NIH | 2/17/2025 | $0 |
| | 2025 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011436 | Development of an HIV infection model of human foreskin to obtain novel insights into virus transmission | 000 | 4 | NIH | 1/13/2025 | -$11,400 |
| | 2025 | 2023 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW011436 | Development of an HIV infection model of human foreskin to obtain novel insights into virus transmission | 001 | 4 | NIH | 1/13/2025 | -$75,702 |
| | 2025 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HG009780 | H3Africa Administrative Coordinating Centre: Enabling and Supporting Genomics and Health Research Capacity Building in Africa | 002 | 5 | NIH | 12/4/2024 | -$539,997 |
| | 2025 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HG006941 | H3ABioNet: informatics solutions for H3Africa | 000 | 10 | NIH | 11/1/2024 | -$255,598 |
| | 2025 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH115484 | Transgenerational Effects of Maternal Stressors: Investigating the Role of Infant Gene Expression | 001 | 5 | NIH | 10/1/2024 | -$8,804 |
| | 2025 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH115484 | Transgenerational Effects of Maternal Stressors: Investigating the Role of Infant Gene Expression | 000 | 5 | NIH | 10/1/2024 | -$9,063 |
| | 2025 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH115484 | Transgenerational Effects of Maternal Stressors: Investigating the Role of Infant Gene Expression | 002 | 5 | NIH | 12/2/2024 | -$19,852 |
| | 2025 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U54HG009790 | Individual Findings in Genetic Research in Africa (IFGeneRA) | 000 | 5 | NIH | 11/1/2024 | -$123,218 |
| | 2025 | 2020 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HG009780 | H3Africa Administrative Coordinating Centre: Enabling and Supporting Genomics and Health Research Capacity Building in Africa | 001 | 4 | NIH | 12/4/2024 | -$241,249 |
| | 2025 | 2020 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HG009780 | H3Africa Administrative Coordinating Centre: Enabling and Supporting Genomics and Health Research Capacity Building in Africa | 000 | 4 | NIH | 12/4/2024 | -$250,000 |
|
| Issue Date FY: 2024 ( Subtotal = $15,190,024 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R33DA053736 | Cape Town Adolescent Antiretroviral Cohort- Substance, Imaging, Mental Health (CTAAC-SIM) | 000 | 4 | NIH | 7/16/2024 | $470,988 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012887 | Metabolomic predictors of weight gain during pregnancy and the postpartum period in South African women living with HIV | 000 | 1 | NIH | 8/23/2024 | $113,048 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2RTW012131 | Computational Omics and Biomedical Informatics Program (COBIP) | 000 | 4 | NIH | 7/30/2024 | $1 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2RTW012131 | Computational Omics and Biomedical Informatics Program (COBIP) | 000 | 4 | NIH | 7/30/2024 | $249,507 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2RTW012131 | Computational Omics and Biomedical Informatics Program (COBIP) | 000 | 4 | NIH | 7/30/2024 | $100,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012864 | Bifidobacterium infantis supplementation in early life to improve neurodevelopment in infants exposed to HIV | 000 | 1 | NIH | 8/15/2024 | $51,762 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012840 | Developing a suicide prevention intervention for people with HIV in South Africa | 000 | 1 | NIH | 8/15/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01MH127692 | Public Understanding of Big data in Genomics Medicine in Africa (PUBGEM-Africa) | 000 | 4 | NIH | 8/27/2024 | $286,254 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R21HD114232 | Functional longevity of maternally derived antibodies against group B Streptococcus and respiratory syncytial virus in HIV-exposed uninfected and HIV-unexposed uninfected infants. | 000 | 1 | NIH | 1/11/2024 | $150,257 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012568 | Developing an in vivo infectious disease training program at the University of Cape Town | 000 | 2 | NIH | 6/5/2024 | $108,226 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U24HG012750 | African Genomics Data Hub Biomedical Knowledgebase | 000 | 2 | NIH | 6/21/2024 | $561,795 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R21HD110305 | Influence of fetal antiretroviral exposure on gut microbiota, systemic inflammation and neurodevelopment in infants exposed to HIV | 000 | 2 | NIH | 2/9/2024 | $140,547 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | K43TW012587 | Insulin-like Growth Factor-1 (IGF-1) signalling in immunometabolism of TB and TB-Diabetes comorbidity | 000 | 2 | NIH | 4/4/2024 | $112,504 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01TW012626 | INnovative data Science to Impact the TB Epidemic - INSITE | 001 | 2 | NIH | 5/6/2024 | $1 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01TW012626 | INnovative data Science to Impact the TB Epidemic - INSITE | 001 | 2 | NIH | 5/6/2024 | $249,735 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | D71TW012504 | A Training Development Plan for HIV-associated Behavioural Medicine | 000 | 2 | NIH | 1/29/2024 | $5,240 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R25TW012219 | Establishing an MSc in Global Health Ethics at the University of Cape Town | 000 | 3 | NIH | 3/23/2024 | $208,798 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U2CEB032224 | eLwazi Open Data Science Platform and Coordinating Center | 000 | 4 | NIH | 8/22/2024 | $2,205,339 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 001 | 5 | NIH | 8/8/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 000 | 5 | NIH | 5/1/2024 | $132,516 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 003 | 4 | NIH | 7/15/2024 | $127,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 003 | 4 | NIH | 7/15/2024 | -$127,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 002 | 4 | NIH | 4/18/2024 | $192,378 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152183 | Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study) | 002 | 4 | NIH | 4/18/2024 | $127,000 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | U01AI152151 | Characterizing intact proviral HIV-1 reservoir size and determinants of reservoir dynamics in African populations | 001 | 5 | NIH | 8/28/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 002 | 5 | NIH | 3/28/2024 | $48,126 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 002 | 5 | NIH | 3/28/2024 | $279,512 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI143636 | Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB | 001 | 5 | NIH | 4/24/2024 | $78,739 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | R01AI143636 | Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB | 000 | 5 | NIH | 2/14/2024 | $728,180 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 001 | 18 | NIH | 6/14/2024 | $888,264 |
| | 2024 | 2024 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | CAPE TOWN | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 18 | NIH | 11/2/2023 | $466,601 |
|
Wednesday, April 2, 2025
4/2/2025
